Interrupting one function of a protein that plays a key role in cell signaling could enable the development of new cancer treatments, according to a study led by Dr. Martin Taylor at the Warren Alpert ...

A new review was published in Volume 13 of Oncoscience on May 22, 2026, titled "Adaptor proteins regulating tumor-associated macrophage polarization during cancer progression." ...

Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites seeding new resistant tumors elsewhere in the body. Combating the problem has ...

A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides fundamental insights into cancer biology. Published in the renowned journal ...

Signal transduction The cellular process that converts a signal, such as a hormone, growth factor, neurotransmitter, cytokine, mechanical force, or environmental cue, into biochemical changes inside ...

A study tracking more than 10,000 patients with early-stage, obesity-related cancers found that those taking GLP-1 receptor ...

But what if they could even help reduce the prevalence of breast cancer? To conduct the analysis, researchers looked at the ...

Millions of women taking semaglutide or similar GLP-1 receptor agonists for diabetes and obesity now have a new data point to weigh: a meta-analysis of randomized placebo-controlled trials, with ...